Luis Miguel Juárez‐Salcedo

ORCID: 0000-0003-1448-8601
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • Histiocytic Disorders and Treatments
  • CAR-T cell therapy research
  • Cutaneous lymphoproliferative disorders research
  • Monoclonal and Polyclonal Antibodies Research
  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Lung Cancer Treatments and Mutations
  • Immunotherapy and Immune Responses
  • Multiple Myeloma Research and Treatments
  • Tumors and Oncological Cases
  • CNS Lymphoma Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Blood groups and transfusion
  • Cancer Immunotherapy and Biomarkers
  • Platelet Disorders and Treatments
  • Breast Lesions and Carcinomas
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Vascular Malformations and Hemangiomas
  • Gastric Cancer Management and Outcomes
  • Prostate Cancer Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation

Hospital Universitario de La Princesa
2022-2025

Hospital General Universitario Gregorio Marañón
2019-2021

Hospital Universitario Príncipe de Asturias
2014-2018

Hospital Universitario de Guadalajara
2018

Hospital Infantil de México Federico Gómez
2017

Moffitt Cancer Center
2016

Instituto Nacional de Cardiología
2014

Fundación Hospital de Jove
2013

Primary gastric lymphoma (PGL) is the most common extranodal non-Hodgkin and represents a wide spectrum of disease, ranging from indolent low-grade marginal zone or mucosa-associated lymphoid tissue (MALT) to aggressive diffuse large B-cell lymphoma. The PGL relatively rare cancer easily misdiagnosed due its unspecific symptoms digestive tract. medical literature ongoing clinical trials were reviewed on presentation, diagnosis, prognosis, prevention, treatment PGL. an event in course with...

10.1177/1073274818778256 article EN cc-by-nc Cancer Control 2018-01-01

Hepatocellular carcinoma (HCC) is in the 10 leading cancer types, being difficult to detect as most of patients who develop this tumor have no symptoms other than those related their long-standing liver disease. The constantly exposed bacterial products, viral infection, alcohol or which may be cause chronic damage, and thus an increasing risk for HCC. Toll-like receptors (TLR) gained extraordinary interest research due role several biological processes such innate immune responses,...

10.1111/hepr.12180 article EN Hepatology Research 2013-06-06

Abstract Background: Prostate cancer (PCa) frequently presents as multifocal lesions with histologic and molecular heterogeneity. A comprehensive understanding of tumor immune responses within the context complex PCa microenvironment remains elusive. Through use Digital Pathology innovative Pathomics image analysis tools, infiltrating lymphocytes (TILs) can be mapped, visualized, quantified in whole slide images (WSIs) H&E stained slides. We have developed a novel workflow to map...

10.1158/1538-7445.am2025-5315 article EN Cancer Research 2025-04-21

A 61-year-old man with a one-month history of progressive mild pancytopenia was referred to the haematology outpatient clinic. He had undergone prior laboratory investigation for this cytopenia without clear diagnosis. full blood count showed haemoglobin concentration 120 g/l, haematocrit 0·37, MCV 101·2 fl, WBC 2·7 × 109/l (neutrophils 1·0 109/l) and platelets 104 109/l. The reticulocyte normal. Biochemical screening including liver function tests peripheral film striking elliptocytosis...

10.1111/bjh.15746 article EN British Journal of Haematology 2018-12-28

Autoimmune cytopenias (AICs) are frequently associated with chronic lymphocytic leukemia (CLL). The most common of these AICs is autoimmune hemolytic anemia (AIHA); the second immune thrombocytopenia (ITP). Here, we report on a patient CLL-associated ITP, refractory to corticosteroids and intravenous immunoglobulins, in which continuous oral treatment Eltrombopag allowed initiation maintenance an anticoagulation Acenocoumarol that was indicated because severe arrhythmogenic cardiomyopathy.

10.1155/2017/9538920 article EN cc-by Case Reports in Hematology 2017-01-01

10.4267/2042/70582 article IT Atlas of Genetics and Cytogenetics in Oncology and Haematology 2019-11-01

10.4267/2042/66948 article EN Atlas of Genetics and Cytogenetics in Oncology and Haematology 2018-04-01

10.4267/2042/70612 article EN Atlas of Genetics and Cytogenetics in Oncology and Haematology 2019-12-01

10.4267/2042/70680 article CA Atlas of Genetics and Cytogenetics in Oncology and Haematology 2020-01-01

10.4267/2042/68529 article Atlas of Genetics and Cytogenetics in Oncology and Haematology 2018-09-01

10.4267/2042/70457 article Atlas of Genetics and Cytogenetics in Oncology and Haematology 2019-09-01
Coming Soon ...